Related Experiment Video
Updated: Aug 8, 2026
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Clinical and biochemical features of autoimmune hepatitis in 36 pediatric patients
Maria Angela Bellomo-Brandão1, Elizete Aparecida Lomazi da Costa-Pinto, Adriana Maria Alves De Tommaso
1Department of Pediatrics, School of Medical Sciences, State University of Campinas, SP, Brazil.
Insights
This study shows that non-Caucasian children with autoimmune hepatitis have similar outcomes to Caucasian children. Treatment with azathioprine and prednisone was effective for autoimmune hepatitis types 1 and 2.
Area of Science:
- Pediatric Hepatology
- Autoimmune Diseases
- Clinical Biochemistry
Background:
- Limited research exists on autoimmune hepatitis (AIH) in non-Caucasian pediatric populations.
- Understanding AIH in diverse ethnic groups is crucial for comprehensive patient care.
Purpose of the Study:
- To assess clinical and biochemical parameters and outcomes in Brazilian children diagnosed with autoimmune hepatitis types 1 and 2.
- To provide insights into the disease course and treatment response in a non-Caucasian pediatric cohort.
Main Methods:
- A protocol evaluated 36 Brazilian children (77% female, median age 11) with AIH types 1 (n=24), 2 (n=7), and unclassified (n=5).
- Data included clinical history, physical examination, biochemical markers, and disease progression.
- Treatment involved azathioprine and prednisone.
Main Results:
- Successful treatment outcomes were observed for both autoimmune hepatitis type 1 and type 2.
- Significant decreases in AST and ALT levels were noted within 4–8 weeks for type 1 AIH.
- Elevated GGT levels normalized within one year for both types; three patients died, and three underwent liver transplantation.
Conclusions:
- Autoimmune hepatitis in non-Caucasian children presents similarly to Caucasian children.
- Elevated GGT levels in the first year of treatment should not solely guide cholangiopathy diagnosis.
Background:
Few studies on autoimmune hepatitis have enrolled non-Caucasian groups.
Aims:
To evaluate Brazilian children with type 1 and 2 autoimmune hepatitis regarding outcome and clinical and biochemical parameters.
Patients And Methods:
Thirty-six patients were submitted to a protocol that evaluated the clinical history, physical and biochemical data, and the course of the disease. Twenty-four children had type 1 autoimmune hepatitis, seven had type 2 and five had unclassified autoimmune hepatitis. Most patients were females (77%), with a median age at diagnosis of 11 years, and the median duration of symptoms was 5.5 and 8 months for types 1 and 2, respectively. Jaundice and choluria were the most common clinical manifestations.
Results:
Treatment with azathioprine and prednisone was successful in patients with type 1 and 2 autoimmune hepatitis. AST and ALT decreased after 4 to 8 weeks of treatment compared to pretreatment levels in type 1 autoimmune hepatitis. Increased GGT values returned to pretreatment levels after 1 year in the two types. Three patients died and three other patients underwent liver transplantation.
Conclusions:
Non-Caucasian children had a similar disease when compared to Caucasian ones with autoimmune hepatitis. Increased levels of GGT during the first year of treatment should not be the only parameter for the indication of cholangiopathy.
Related Concept Videos
01:12Type I Diabetes I: Introduction
01:25Hepatitis